Debt-to-equity of Barinthus Biotherapeutics plc. from 31 Mar 2023 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Barinthus Biotherapeutics plc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2023 to 30 Sep 2025.
Barinthus Biotherapeutics plc. Debt-to-equity for the quarter ending 30 Sep 2025 was 25%, a 48% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Barinthus Biotherapeutics plc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	25%	+8.1%	+48%	30 Sep 2025
Q2 2025	22%	+5.5%	+33%	30 Jun 2025
Q1 2025	21%	+5.3%	+35%	31 Mar 2025
Q4 2024	19%	+4.6%	+33%	31 Dec 2024
Q3 2024	17%	+3.6%	+27%	30 Sep 2024
Q2 2024	17%	+4.5%	+37%	30 Jun 2024
Q1 2024	15%	+3.3%	+28%	31 Mar 2024
Q4 2023	14%			31 Dec 2023
Q3 2023	13%			30 Sep 2023
Q2 2023	12%			30 Jun 2023
Q1 2023	12%			31 Mar 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.